Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial

Heather M Johnson1, Linda K Gossett, Megan E Piper

  • 1University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA.

Insights

Smoking cessation significantly improves endothelial function, specifically flow-mediated dilation (FMD) of the brachial artery. These improvements in vascular health persist long-term, contributing to reduced cardiovascular disease risk in former smokers.

Area of Science:

  • Cardiovascular Research
  • Endothelial Function Studies
  • Smoking Cessation Research

Background:

  • Long-term effects of smoking and cessation on endothelial function remain under-described.
  • Endothelial dysfunction is a key factor in smoking-related cardiovascular disease.

Purpose of the Study:

  • To determine if smoking cessation improves brachial artery flow-mediated dilation (FMD).
  • To assess the long-term impact of smoking cessation on endothelial function.

Main Methods:

  • A 1-year, prospective, double-blind, randomized, placebo-controlled trial involving 1,504 smokers.
  • Flow-mediated dilation (FMD) measured via B-mode ultrasonography; cessation verified by carbon monoxide levels.
  • Comparison of FMD changes between quitters and continued smokers; multivariable regression identified predictors of FMD.

Main Results:

  • 36.2% of participants successfully quit smoking after 1 year.
  • Flow-mediated dilation (FMD) increased significantly in quitters (6.2% to 7.2%, p=0.005), but not in those who continued smoking.
  • Improved FMD in quitters remained significant after controlling for confounding factors.

Conclusions:

  • Smoking cessation leads to sustained improvements in endothelial function, despite potential weight gain.
  • These vascular improvements may partially explain the reduced cardiovascular disease risk associated with quitting smoking.
  • Pharmacotherapies for smoking cessation are effective in improving endothelial health.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Lifestyle Factors and Health01:20

Lifestyle Factors and Health

Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...